KFDA to face lawsuit

Published: 2006-10-12 07:00:00

Updated: 2006-10-12 07:00:00

12 pharmaceutical firms, including Dong-A Pharm and Whanin Pharm, said recently it will file a suit with a Seoul court against the Korea Food and Drug Administration (KFDA) for its improper license cancellation of their products involved in generic drugs' efficacy fabrication.

In the suit to b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK